Neuberger Berman Group’s Takeda Pharmaceutical TAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Buy |
34,242
+3,533
| +12% | +$54.6K | ﹤0.01% | 1551 |
|
|
2025
Q1 | $457K | Buy |
30,709
+5,034
| +20% | +$74.9K | ﹤0.01% | 1543 |
|
|
2024
Q4 | $340K | Buy |
25,675
+9,081
| +55% | +$120K | ﹤0.01% | 1637 |
|
|
2024
Q3 | $236K | Buy |
16,594
+6,100
| +58% | +$86.7K | ﹤0.01% | 1740 |
|
|
2024
Q2 | $136K | Sell |
10,494
-5,533
| -35% | -$71.6K | ﹤0.01% | 1790 |
|
|
2024
Q1 | $223K | Buy |
+16,027
| New | +$223K | ﹤0.01% | 1714 |
|
|
2020
Q2 | – | Sell |
-10,808
| Closed | -$164K | – | 1591 |
|
|
2020
Q1 | $164K | Buy |
+10,808
| New | +$164K | ﹤0.01% | 1437 |
|